Literature DB >> 9343129

Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery.

Y B Roos1, L F Beenen, R J Groen, K W Albrecht, M Vermeulen.   

Abstract

OBJECTIVE: To investigate prospectively the proportion of patients actually operated on early in units that aim at surgery in the acute phase of aneurysmal subarachnoid haemorrhage (SAH) and what is the main current determinant of poor outcome.
METHODS: A prospective analysis of all SAH patients admitted during a one year period at three neurosurgical units that aim at early surgery. The following clinical details were recorded: age, sex, date of SAH, date of admission to the neurosurgical centre, whether a patient was referred by a regional hospital or a general practitioner, Glasgow coma scale and grade of SAH (World Federation of Neurological Surgeons (WFNS) score) on admission at the neurosurgical unit, results of CT and CSF examination, the presence of an aneurysm on angiography, details of treatment with nimodipine or antifibrinolytic agents, and the date of surgery to clip the aneurysm. At follow up at three months, the patients' clinical outcome was determined with the Glasgow outcome scale and in cases of poor outcome the cause for this was recorded.
RESULTS: The proportion of patients that was operated on early--that is, within three days after SAH--was 55%. Thirty seven of all 102 admitted patients had a poor outcome. Rebleeding and the initial bleeding were the main causes of this in 35% and 32% respectively of all patients with poor outcome.
CONCLUSIONS: In neurosurgical units with what has been termed "modern management" including early surgery, about half of the patients are operated on early. Rebleeding is still the major cause of poor outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9343129      PMCID: PMC2169792          DOI: 10.1136/jnnp.63.4.490

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

2.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

Authors:  M R Mayberg; H H Batjer; R Dacey; M Diringer; E C Haley; R C Heros; L L Sternau; J Torner; H P Adams; W Feinberg
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

3.  Assessment of outcome after severe brain damage.

Authors:  B Jennett; M Bond
Journal:  Lancet       Date:  1975-03-01       Impact factor: 79.321

4.  Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations.

Authors:  H B Locksley
Journal:  J Neurosurg       Date:  1966-09       Impact factor: 5.115

Review 5.  Antifibrinolytic therapy and cerebral vasospasm.

Authors:  E C Haley; J C Torner; N F Kassell
Journal:  Neurosurg Clin N Am       Date:  1990-04       Impact factor: 2.509

6.  Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington.

Authors:  W T Longstreth; L M Nelson; T D Koepsell; G van Belle
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

7.  Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage.

Authors:  J P Broderick; T G Brott; J E Duldner; T Tomsick; A Leach
Journal:  Stroke       Date:  1994-07       Impact factor: 7.914

8.  Aneurysmal bleeding. A plea for early surgery in good-risk patients.

Authors:  R T Thomeer; J C Taal; J H Voormolen; A R Wintzen
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.

Authors:  N F Kassell; E C Haley; C Apperson-Hansen; W M Alves
Journal:  J Neurosurg       Date:  1996-02       Impact factor: 5.115

10.  An audit of aneurysmal subarachnoid haemorrhage: earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding.

Authors:  P C Whitfield; H Moss; D O'Hare; P Smielewski; J D Pickard; P J Kirkpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

View more
  23 in total

1.  Lesson of the week: Playing the odds in clinical decision making: lessons from berry aneurysms undetected by magnetic resonance angiography.

Authors:  M R Johnson; C D Good; W D Penny; P R Barnes; J W Scadding
Journal:  BMJ       Date:  2001-06-02

2.  Subarachnoid haemorrhage and intracranial aneurysms: what neurologists need to know.

Authors:  P J Kirkpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

3.  Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study.

Authors:  N Ross; P J Hutchinson; H Seeley; P J Kirkpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

4.  Considerations about ultra-early treatment of ruptured aneurysms.

Authors:  Michel W Bojanowski
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

Review 5.  Rebleeding after aneurysmal subarachnoid hemorrhage.

Authors:  R M Starke; E S Connolly
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

6.  Acute endovascular treatment of ruptured aneurysms in poor-grade patients.

Authors:  M Bergui; G B Bradac
Journal:  Neuroradiology       Date:  2003-12-20       Impact factor: 2.804

Review 7.  Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.

Authors:  Mark Chwajol; Robert M Starke; Grace H Kim; Stephan A Mayer; E Sander Connolly
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Time intervals from subarachnoid hemorrhage to rebleed.

Authors:  M R Germans; B A Coert; W P Vandertop; D Verbaan
Journal:  J Neurol       Date:  2014-05-08       Impact factor: 4.849

9.  Time intervals from aneurysmal subarachnoid hemorrhage to treatment and factors contributing to delay.

Authors:  Menno Robbert; Menno R Germans; Jantien Hoogmoed; H A Stéphanie van Straaten; Bert A Coert; W Peter Vandertop; Dagmar Verbaan
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

10.  Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding.

Authors:  Ynte M Ruigrok; Arjen J C Slooter; Gabriel J E Rinkel; Cisca Wijmenga; Frits R Rosendaal
Journal:  Acta Neurochir (Wien)       Date:  2009-10-14       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.